Charles Sainsbury
SHEIN APPLIES FOR IPO IN THE USA
According to sources familiar with the matter, the fashion company has filed Shein has filed a confidential application to list in the United States. In doing so, it is likely to be one of the the most valuable companies founded in Chinathat will go public New York market.
Companies have been hired as lead underwriters in the IPO Goldman Sachs,...
Read more
PERION and prosperity compared to other ADTECH companies
Perion Network Ltd. OVERVIEW
- Over the past year, shares of advertising companies have seen a slight recovery, compared to previous years.
- However,$PERI+1.8% has achieved double-digit revenue growth and is approaching a 20% net profit margin in 2023.
Investment Opportunity with Perion:
-$PERI+1.8% offers a rare combination...
Read more
KASPI.KZ KAZAKHSTAN'S IPO WHICH CONQUERS NASDAQ
1. Superapplication Kaspi $KSPI.L-1.5%:
- Combines elements of Amazon, PayPal, Affirm and WeChat.
- Founded in Kazakhstan in 2008.
- Provides a range of services from e-commerce and payments to fintech and banking functions.
2. IPO and Financial Data:
- IPO on Nasdaq with value 1 billion dollars.
- Company valuation of approx. 17.5...
Read more
ELI LILLY AS A POSSIBLE GAMECHANGER IN THE HEALTHCARE SECTOR
-Eli Lilly $LLY+1.8% is currently the most valuable healthcare company in the world, valued at around $550 billion.
- The company's stock has been one of the most sought-after in the healthcare sector.
- Despite the high value, there are many growth opportunities for Eli Lilly in the pharmaceutical industry.
- Donanemab...
Read more
Zobrazit další komentáře
If one looks at the chart from a long-term perspective, one finds that the company has never sold off properly except in 2000 and is still rising. That's great for stock owners, but for new investors given the valuation, I think it's high. But on the stock, that doesn't mean the growth is over. The company can continue to strengthen. I don't own it and I'm not thinking about buying it at this time.
1. **NEW NORDISK $NVO+2.5% ATTRACTIVE GROWTH INVESTMENT**
- Novo Nordisk is a Danish pharmaceutical company with excellent financial growth. -
It is currently attracting the attention of growth investors in the market.
2. **Key factors for investors:**
- Earnings growth: Historically, the company has earnings per share (EPS) growth of 13.5%, with expected growth for this year of up...
Read more
Interesting tip, I like it when someone comes up with a company completely out of places where you probably don't normally look for stocks. 😊 I don't know the company of course. Where do you get these companies and then where do you trade them if applicable? 😊